Rymedi 和 Precision Genetics 联手实现精准医学突破

Rymedi 和 Precision Genetics 的突破性合作旨在通过精准医疗彻底改变医疗保健。 Precision Genetics 的 PrecisionOp 解决方案可减轻手术中的药物不良反应，而 Rymedi 的临床试验平台使 Precision Genetics 的 PROMISRx 注册表能够识别药物反应的预测因素。该联盟集成了 Web3、DeSci 和区块链技术（在 Rymedi 的 Avalanche 子网上无缝管理），以提高患者治疗效果，强调 Rymedi 对去中心化医疗保健解决方案的承诺，并重塑医疗保健范例。

Rymedi and Precision Genetics Forge Strategic Alliance to Advance Precision Medicine

Rymedi 与 Precision Genetics 结成战略联盟，推进精准医学

In a groundbreaking collaboration, Rymedi and Precision Genetics, two industry leaders in healthcare technology, have announced a strategic partnership that aims to revolutionize health outcomes and operational efficiency through the transformative power of precision medicine.

在一项开创性的合作中，医疗保健技术领域的两家行业领导者 Rymedi 和 Precision Genetics 宣布建立战略合作伙伴关系，旨在通过精准医疗的变革力量彻底改变健康结果和运营效率。

PrecisionOp: Personalized Solutions for Safer Surgeries

PrecisionOp：实现更安全手术的个性化解决方案

Precision Genetics contributes its flagship offering, PrecisionOp, to the partnership. PrecisionOp is a personalized solution that aims to mitigate adverse drug reactions and reduce reliance on post-operative opioids for surgical patients. By tailoring drug regimens based on genetic information, PrecisionOp minimizes risks and optimizes recovery after surgery, empowering clinicians with data-driven insights that can lead to better patient outcomes.

Precision Genetics 为此次合作贡献了其旗舰产品 PrecisionOp。 PrecisionOp 是一种个性化解决方案，旨在减轻药物不良反应并减少手术患者对术后阿片类药物的依赖。通过根据遗传信息定制药物治疗方案，PrecisionOp 可最大限度地降低风险并优化术后恢复，为临床医生提供数据驱动的见解，从而改善患者的治疗效果。

Rymedi's Blockchain-Enabled Clinical Trial Platform

Rymedi 的区块链临床试验平台

Rymedi's clinical trial and registry platform plays a pivotal role in this partnership. It will support Precision Genetics' ambitious research study: Prospective Outcomes & Molecular Implementation Support Registry (PROMISRx). PROMISRx focuses on tracking, analyzing, and identifying predictors of medication response in surgical patients. Armed with genetic insights, clinicians can fine-tune treatment plans, enhancing patient outcomes and minimizing the risks associated with trial-and-error approaches.

Rymedi 的临床试验和注册平台在此次合作中发挥着关键作用。它将支持 Precision Genetics 雄心勃勃的研究：前瞻性结果和分子实施支持注册中心 (PROMISRx)。 PROMISRx 专注于跟踪、分析和识别手术患者药物反应的预测因子。凭借遗传见解，临床医生可以微调治疗计划，改善患者的治疗效果并最大限度地降低与试错方法相关的风险。

David Stefanich's Vision: Web3 and DeSci Solutions

David Stefanich 的愿景：Web3 和 DeSci 解决方案

David Stefanich, CEO and Founder of Rymedi, emphasizes the global impact of this partnership. It signifies Rymedi's commitment to integrating Web3 and decentralized science (DeSci) solutions into clinical trial management, leveraging the power of blockchain technology to enhance healthcare efficiency and transparency. The marriage of blockchain technology and precision medicine holds immense promise for the healthcare industry, opening up new possibilities for data sharing, collaboration, and patient engagement.

Rymedi 首席执行官兼创始人 David Stefanich 强调了此次合作的全球影响力。它标志着 Rymedi 致力于将 Web3 和去中心化科学 (DeSci) 解决方案整合到临床试验管理中，利用区块链技术的力量来提高医疗保健效率和透明度。区块链技术和精准医疗的结合为医疗保健行业带来了巨大的希望，为数据共享、协作和患者参与开辟了新的可能性。

Avalanche Subnets: Rymedi's Infrastructure Management

Avalanche 子网：Rymedi 的基础设施管理

Rymedi efficiently manages its operations across three distinct Avalanche subnets. From deployment to scaling, their internal development team oversees the entire infrastructure. Zeeve, a compliant BlaaS (Blockchain as a Service) platform, ensures enterprise-grade security, performance, and reliability, providing a robust foundation for the partnership's initiatives.

Rymedi 有效管理三个不同 Avalanche 子网的运营。从部署到扩展，他们的内部开发团队负责监督整个基础设施。 Zeeve 是一个合规的 BlaaS（区块链即服务）平台，可确保企业级安全性、性能和可靠性，为合作伙伴的计划提供坚实的基础。

A Paradigm Shift in Healthcare

医疗保健的范式转变

In summary, Rymedi and Precision Genetics are poised to reshape healthcare paradigms. Their strategic partnership bridges cutting-edge technology with patient-centric care, ushering in an era of precision medicine for all. By harnessing the power of data, genetics, and blockchain, they aim to revolutionize treatment strategies, improve patient outcomes, and streamline clinical trial processes, ultimately delivering a future where healthcare is tailored to the unique needs of each individual.

总之，Rymedi 和 Precision Genetics 准备重塑医疗保健范式。他们的战略合作伙伴关系将尖端技术与以患者为中心的护理联系起来，开创了全民精准医疗的时代。通过利用数据、遗传学和区块链的力量，他们的目标是彻底改变治疗策略、改善患者治疗结果并简化临床试验流程，最终实现一个根据每个人的独特需求量身定制医疗保健的未来。